NCT00626808View on ClinicalTrials.gov

A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children

CompletedOBSERVATIONAL

Enrollment

321,697

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

AsthmaWheezingImmunosuppression

Interventions

DRUG

No Intervention

There were no interventions. No subjects were enrolled in this retrospective database study.

Trial Locations (1)

Unknown

Research Site, Research Triangle Park

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

RTI International

OTHER

lead

MedImmune LLC

INDUSTRY

NCT00626808 - A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children | Biotech Hunter | Biotech Hunter